THE PRESENT INVENTION PROVIDES (5-METHYL-2-OXO-1,3-DIOXOL- 4-YL)METHYL 2-CYCLOPROPYL-1-([2'-(5-OXO-4,5-DIHYDRO-1,2,4- OXADIAZOL-3-YL)BIPHENYL-4-YL]METHYL)-1H-BENZIMIDAZOLE-7- CARBOXYLATE REPRESENTED BY THE FORMULA: WHICH HAS SUPERIOR PROPERTIES AS A PHARMACEUTICAL AGENT, A SALT THEREOF, A CRYSTAL THEREOF, A PHARMACEUTICAL AGENT CONTAINING THE COMPOUND, AND THE LIKE.